Lukas Raab
Overview
Explore the profile of Lukas Raab including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reindl-Schwaighofer R, Heinzel A, Raab L, Strassl R, Herz C, Regele F, et al.
EBioMedicine
. 2024 Oct;
109:105417.
PMID: 39442367
Background: The response to severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) vaccination is severely impaired in patients on maintenance immunosuppression after kidney transplantation. Methods: We conducted a prospective cohort...
2.
Heinzel A, Schrezenmeier E, Regele F, Hu K, Raab L, Eder M, et al.
Front Med (Lausanne)
. 2022 Oct;
9:1048395.
PMID: 36300193
[This corrects the article DOI: 10.3389/fmed.2022.936126.].
3.
Heinzel A, Schrezenmeier E, Regele F, Hu K, Raab L, Eder M, et al.
Front Med (Lausanne)
. 2022 Aug;
9:936126.
PMID: 35935786
Response to SARS-CoV-2-vaccines in kidney-transplant recipients (KTR) is severely reduced. Heterologous3 vaccination combining mRNA and vector vaccines did not increase seroconversion at 4 weeks after vaccination, but evolution of antibody...
4.
Regele F, Heinzel A, Hu K, Raab L, Eskandary F, Fae I, et al.
Front Med (Lausanne)
. 2022 Jun;
9:914424.
PMID: 35755078
Introduction: Kidney transplant recipients (KTR) are at high risk of developing severe COVID-19. However, vaccine response in this population is severely impaired with humoral response rates of 36-54 and 55-69%...